Alkermes plc
(ALKS - NASDAQ)
46,10 USD
📋 Profilo Aziendale

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

|